Vericel Corporation
(VCEL - NASDAQ)
36,92 USD
📋 Profilo Aziendale

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States.

|